- Overview
- EIFU & Resources
Facilimix™ Compounding Device is designed to eliminate syringe push/pull motions.
Intuitive to use, as the device mimics syringe motion, it enables to withdraw and inject compound with one finger.
The Facilimix™ Cartridge is a dedicated patented* double seal syringe designed for use with the Facilimix™ Compounding Device.
Compatible with oncology drugs including paclitaxel4,5 the standard luer lock cartridge has a double seal to increase accuracy and avoid leakage.
Facilimix™ in use with BD Texium™
Facilimix™ in use with BD PhaSeal™
Facilimix™ in use with BD PhaSeal™ Optima
Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.
*patent number: US 2013/0199668 A1
References
F. Reisz, AC. Gairard-Dory, K. Fonmartin, J. Bourbon, B. Gourieux. Prévention des troubles musculo squelettiques en pharmacotechnie. Groupe d’évalutation de recherche sur la protection en atmosphère contrôlée (GERPAC).
GERPAC . Accessed on May 6, 2018.
The National Institute for Occupational Safety and Health (NIOSH) Safe patient handling and mobility (SPHM).
Safe Patient Handling and Mobility (SPHM) | NIOSH | CDC . Accessed June, 2019.Nancy N. Byl, Mary F. Barbe, Carolyn Byl Dolan, Grant Glass. Repetitive Stress Pathology: Soft Tissue in Pathology and Intervention in Musculoskeletal Rehabilitation. Second Edition 2016, Pages 938-1004.
Dr. Federico Reverberi. Paclitaxel stability in physiologic solution after contact with medical device. August 2016
J. Vignerona et al. SFPO and ESOP recommendations for the practical stability of anticancer drugs: An update. Annales Pharmaceutiques Françaises (2013) 71, 376—389
BD-22023